Studies
A Genome Wide Scan of Lung Cancer and Smoking
A Genome Wide Scan of Lung Cancer and Smoking
Request Access
Overview
Selected Publications (6)
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
P. Prorok, G. Andriole, R. Bresalier, et al.. (2000). Controlled clinical trials. Cited 1,010 times.
https://doi.org/10.1016/S0197-2456(00)00098-2
Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival
M. Landi, T. Dracheva, Melissa Rotunno, et al.. (2008). PLoS ONE. Cited 656 times.
https://doi.org/10.1371/journal.pone.0001651
Environment And Genetics in Lung cancer Etiology (EAGLE) study: An integrative population-based case-control study of lung cancer
M. Landi, Dario Consonni, Melissa Rotunno, et al.. (2008). BMC Public Health. Cited 173 times.
https://doi.org/10.1186/1471-2458-8-203
Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.
M. Oken, P. Marcus, P. Hu, et al.. (2005). Journal of the National Cancer Institute. Cited 132 times.
https://doi.org/10.1093/JNCI/DJI430
Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.
N. K. Simpson, C. C. Johnson, S. Ogden, et al.. (2000). Controlled clinical trials. Cited 59 times.
https://doi.org/10.1016/S0197-2456(00)00102-1
Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial
Sophia S. Wang, L. Morton, A. Bergen, et al.. (2007). Human Genetics. Cited 17 times.
https://doi.org/10.1007/s00439-007-0374-7
